Revlimid 10 MG capsule 28S
Ended Awarded
- Contract number
- SPE2DB25FVW68
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $205,948
Award facts
- Contract value 100% obligated
- $205,948.11 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp has been awarded a delivery order contract by the Defense Logistics Agency (DLA) for the supply of Revlimid 10 mg capsules (28-count) with a ceiling value of $205,948.11. The contract, which is not set-aside, carries a firm fixed price and was awarded on May 30, 2025, with an ultimate completion date of June 23, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capability in meeting federal medical procurement requirements through its extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain. The delivery order supports military and veteran healthcare systems by providing critical pharmaceutical products, and reflects the company's role as a primary vendor for the federal government's pharmaceutical supply needs. The DLA's Medical Supply Chain relies on vendors like AmerisourceBergen to ensure consistent access to brand-name and generic medications, specialty pharmaceuticals, and related medical commodities across multiple therapeutic domains to support defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FVW68?
SPE2DB25FVW68 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FVW68 worth?
The government has obligated $205,948 on SPE2DB25FVW68.
Is contract SPE2DB25FVW68 an order under another contract?
Yes. SPE2DB25FVW68 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FVW68 competed?
The extent of competition for SPE2DB25FVW68 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award